Using iterative rounds of in vivo screening in murine syngeneic tumor models, a mixture of four synthetic mRNAs encoding bioactive versions of interleukin-12, interferon alpha, GM-CSF and interleukin-15 was identified which mediated complete tumor regression across multiple different tumor models. The gene discussed is CSF2; the disease is neoplasm.